Takeda Pharmaceutical
TAK
#434
Rank
$56.01 B
Marketcap
$17.73
Share price
-0.89%
Change (1 day)
35.03%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): $3.32 Billion USD

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are $29.86 Billion USD. , an increase over its 2024 earnings that were of $2.23 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 $3.32 B49.03%
2024 $2.23 B-2.41%
2023 $2.28 B-28.14%
2022 $3.18 B-40.9%
2021 $5.38 B78.24%
2020 $3.02 B246.1%
2019 $0.87 B-48.79%
2018 $1.70 B-23.64%
2017 $2.23 B21.7%
2016 $1.83 B-253.01%
2015 -$1.2 Billion-159.65%
2014 $2.00 B13%
2013 $1.77 B2.46%
2012 $1.73 B-57.05%
2011 $4.03 B-10.49%
2010 $4.51 B-3.99%
2009 $4.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$32.39 B 874.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.35 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$11.85 B 256.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.24 B 147.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.10 B 173.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$23.09 B 594.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$9.32 B 180.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-$0.8 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
$0.87 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India